Supreme Court asked to review abortion law signed by Pence
Indiana is asking the U.S. Supreme Court to hear arguments over a law that bars women from having an abortion based on gender, race or disability.
Health Care & Insurance
Articles
BioCrossroads forms $9M seed fund for life science startups
The Indiana Seed Fund III is an early-stage fund focused on developing startups in life sciences, health IT and agricultural biosciences.
Deal with national pharmacy spurs tech company’s growth
An Indianapolis-based company has signed a deal with national mail-order pharmacy GoGoMeds that officials project will help double its local workforce—to about 250—within five years.
Indy-based ER physicians’ group sues Fayette Regional Health for fraud, breach of contract
The physicians’ group claims the Connersville health system misled it on patient volumes and has refused to adjust a subsidy to make up the difference.
CVS-Aetna deal given go-ahead by U.S. antitrust regulators
The Justice Department’s approval clears the way for a merger that will create a health care giant with a hand in insurance, prescription-drug benefits and drugstores across the United States.
Hunger, food insecurity continue to vex Indiana residents
In Indiana, one million people face food insecurity, and in Indianapolis the number is approaching nearly 175,000—or more than 18 percent of the population.
Generic drugmakers get boost as FDA plan helps complex copycats
The U.S. Food and Drug Administration will make it easier for pharmaceutical companies to bring more complex—and more profitable—generic drugs to market, throwing the struggling industry a crucial lifeline.
IU researcher wins $44.7M to study rare form of Alzheimer’s disease
The IU School of Medicine said the grant, its largest-ever National Institutes of Health award, will fund a five-year study of a form of Alzheimer’s disease that affects young people.
Lilly might market diabetes drug for obesity after research results
Eli Lilly and Co.’s stock jumped Thursday after midstage research on an experimental diabetes drug showed significant weight loss in patients. The news took a toll on shares of rival Novo Nordisk.
Hospitals hit with fines over patient readmissions
Indiana hospitals are racking up millions of dollars in penalties for having too many patients return for care within a month of discharge.
Roche using data-driven diagnostic tools to reshape patient care
The company, which employs more than 3,000 on the northeast side, has been struggling on the diabetes side of its business. To bounce back, it is investing heavily in diagnostics, and is working to commercialize several products it hopes will be game-changers.
Matthew Neff: More lessons learned from the Theranos debacle
Theranos kept the plates spinning longer than most could have, in the rigorous world of peer-reviewed science, by blending secrecy and the appearance of credibility from the supporters Holmes had enlisted. But in the end, no one could have kept all the plates spinning.
Thousands of insurance appeals went to doctor feds say is fraud
Former orthopedic surgeon Spyros Panos seemed like a successful orthopedic surgeon, but he’s accused of a decade-long stretch of criminal activity that netted him millions of dollars. Among the companies that indirectly used Panos' services was Indianapolis-based Anthem Inc.
Big gymnasium in downtown corporate campus to be demolished
The owner of the 40,000-square-foot gym says upgrading the facility would cost tens of millions of dollars, and that the cost to maintain it is greater than the property’s value.
Employers jump into providing care for workers as health costs rise
Fiat Chrysler in central Indiana is among those offering basic health care for most of its employees and their families through its factory-based clinics.
Opioid epidemic showing signs of turning corner, state drug czar says
Visits to emergency rooms in Indiana for drug overdoses are falling, and doctors are writing fewer prescriptions for opioid painkillers, Jim McClelland said Friday.
Migraine drug from Eli Lilly approved by FDA
Eli Lilly and Co. received clearance Thursday from U.S. regulators for a new migraine drug that will be the third in a promising class of therapies for patients who suffer from the recurrent, painful headaches.
Trump health chief: Premiums to drop for popular ACA plan
Health and Human Services Secretary Alex Azar said premiums for a so-called "benchmark" silver plan will drop by 2 percent in the 39 states served by the federal HealthCare.gov website.
St. Vincent to buy 30 acres in Carmel—site of earlier controversy with neighbors
The Indianapolis health system said it has not yet decided how to develop the site, but wants to keep its options open. It dropped plans four months ago to rezone the land after neighbors objected.
Ranking hospitals is serious business, but do patients pay attention?
Indiana University Health isn’t shy about telling the world how it stacks up in U.S. News & World Report’s “Best Hospital” annual rankings.